| Dr Julie Elizabeth Haberstroh, DDS | |
|
12101 E 2nd Ave, Suite 206, Aurora, CO 80011 | |
| (303) 343-2161 | |
| Not Available |
| Full Name | Dr Julie Elizabeth Haberstroh |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 12101 E 2nd Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144235672 | NPI | - | NPPES |
| 02051910 | Medicaid | CO | |
| 68685 | Other | CO | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 105191 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julie Elizabeth Haberstroh, DDS 6025 E 1st Ave, Denver, CO 80220 Ph: (303) 399-3755 | Dr Julie Elizabeth Haberstroh, DDS 12101 E 2nd Ave, Suite 206, Aurora, CO 80011 Ph: (303) 343-2161 |
News Archive
The duration of undiagnosed bipolar disorder is unrelated to patients' clinical status or their response to mood-stabilising medication, study findings indicate.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
A team of California-based breast imagers and breast cancer risk specialists have developed a website to help navigate the new challenges posed by breast density notification laws, according to a special report published online in the journal Radiology.
Reaction Progress Kinetic Analysis (RPKA) streamlines kinetic studies by exploiting extensive data available from accurate in situ monitoring of global reaction progress under synthetically relevant conditions, where the concentrations of two or more reactants are changing simultaneously – in fact, in the same manner that they are expected to change during practical synthesis.
A case report, published in The Lancet today, describes the successful treatment of Ebola using a new drug under clinical development for vascular leakage (FX06, a fibrin-derived peptide).
› Verified 1 days ago
Dr. Alfred Patrick Smithwick Iii, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 22986 E Smoky Hill Rd, Aurora, CO 80016 Phone: 443-756-7119 | |
Dr. Syed Shafay Yaqeen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2200 North Nursula Street Buildng 5 Apt 444, Aurora, CO 80045 Phone: 682-313-5321 | |
Dr. Ricky Eugene Harrell, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 13065 E 17th Pl, Aurora, CO 80045 Phone: 303-724-0725 | |
Dr. William Randall Sanders Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3100 S Parker Rd, Suite 103, Aurora, CO 80014 Phone: 303-337-2794 Fax: 303-337-2848 | |
Dr. Lucas Nguyen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 797 Peoria St Ste A, Aurora, CO 80011 Phone: 303-577-0062 | |
Dr. Marwan Al-barrak, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3507 S Cathay St, Aurora, CO 80013 Phone: 404-245-3604 | |
Dr. Mun J. Choi, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1075 S Peoria St, Aurora, CO 80012 Phone: 303-577-0377 |